DeepMed Research

UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Use of Omega-3 Fatty Acids for Perinatal Depression

Phase 2

Completed

Conditions: Depression
Depression, Postpartum

Interventions: Drug: Omega-3 Fatty Acids (EPA plus DHA)
Behavioral: Supportive psychotherapy
Drug: Placebo

First Posted Date: 2006-11-22

Last Posted Date: 2013-03-29

Lead Sponsor: University of Arizona

Target Recruit Count: 50

Registration Number: NCT00402389

Locations: 🇺🇸
Women's Mental Health Program; University of Arizona; Department of Psychiatry, Tucson, Arizona, United States

Family Consultation for Health-Compromised Smokers

Phase 1

Completed

Conditions: Nicotine Dependence

First Posted Date: 2006-11-17

Last Posted Date: 2006-11-17

Lead Sponsor: University of Arizona

Target Recruit Count: 40

Registration Number: NCT00400751

Locations: 🇺🇸
University of Arizona, Family Research Laboratory, Dept of Psychology, Tucson, Arizona, United States

Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease

Completed

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2006-11-02

Last Posted Date: 2017-12-06

Lead Sponsor: University of Arizona

Target Recruit Count: 2085

Registration Number: NCT00394940

Locations: 🇺🇸
Arizona Respiratory Center, Tucson, Arizona, United States

Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer

Not Applicable

Completed

Conditions: Depression
Psychosocial Effects of Cancer and Its Treatment
Colorectal Cancer
Anxiety Disorder

First Posted Date: 2006-09-07

Last Posted Date: 2010-05-27

Lead Sponsor: University of Arizona

Target Recruit Count: 45

Registration Number: NCT00373022

Locations: 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Bupropion Treatment for Youth Smoking Cessation

Phase 3

Completed

Conditions: Nicotine Dependence

First Posted Date: 2006-06-27

Last Posted Date: 2006-06-27

Lead Sponsor: University of Arizona

Registration Number: NCT00344695

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis

Not Applicable

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2006-05-18

Last Posted Date: 2006-05-18

Lead Sponsor: University of Arizona

Target Recruit Count: 35

Registration Number: NCT00327275

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)

Phase 4

Completed

Conditions: Gastroesophageal Reflux Disease

Interventions: Drug: Standard dose (once daily) PPI plus low-dose antidepressant
Drug: Double dose PPI plus evening placebo
Drug: Rabeprazole , placebo, placebo

First Posted Date: 2005-11-10

Last Posted Date: 2010-08-19

Lead Sponsor: University of Arizona

Target Recruit Count: 150

Registration Number: NCT00251732

Locations: 🇺🇸
Southern Arizona VA Health Care System, Tucson, Arizona, United States

Acupuncture as Complementary Therapy for Cerebral Palsy

Phase 2

Completed

Conditions: Cerebral Palsy

Interventions: Procedure: Acupuncture

First Posted Date: 2005-09-22

Last Posted Date: 2016-05-16

Lead Sponsor: University of Arizona

Target Recruit Count: 75

Registration Number: NCT00221247

Locations: 🇨🇳
Beijing Children's Hospital, Beijing, Beijing, China
🇺🇸
The University of Arizona, Department of Pediatrics, Tucson, Arizona, United States

Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Neoplasms

Interventions: Drug: bevacizumab
Drug: erlotinib

First Posted Date: 2005-08-15

Last Posted Date: 2012-05-28

Lead Sponsor: University of Arizona

Target Recruit Count: 40

Registration Number: NCT00130520

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

Not Applicable

Completed

Conditions: brca1 Mutation Carrier
brca2 Mutation Carrier
Ovarian Cancer

First Posted Date: 2004-12-09

Last Posted Date: 2010-03-24

Lead Sponsor: University of Arizona

Target Recruit Count: 40

Registration Number: NCT00098800

Locations: 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy